+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Glycan Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Glycan Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Aldosterone Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Aldosterone Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiotensin Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PDE 10 inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

PDE 10 inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Potassium Channel Openers - Pipeline Insight, 2024 - Product Thumbnail Image

Potassium Channel Openers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Reversible Anticholinesterases - Pipeline Insight, 2024 - Product Thumbnail Image

Reversible Anticholinesterases - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Placenta growth factor inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Placenta growth factor inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more